Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity".
We used cells from marrow aspirations that had been performed on 10 infants with the "anemia of prematurity" and tested the responsiveness of their erythroid colony-forming units (CFU-E) to recombinant human erythropoietin. For comparison, we also tested marrow-derived CFU-E from five healthy adults, and circulating CFU-E from cord blood of five healthy neonates. CFU-E from the anemic infants had a 50% maximal response at 0.073 +/- 0.024 U erythropoietin per milliliter (mean +/- SD). They were therefore at least as responsive as were CFU-E from adults, which displayed a 50% maximal response at 0.118 +/- 0.076 U/ml, and as were circulating CFU-E of cord blood origin, which had a 50% maximal response at 0.109 +/- 0.047 U/ml. Because CFU-E from infants with the "anemia of prematurity" appeared highly sensitive to erythropoietin in vitro, we propose that its administration to these patients would likely result in a significant increase in erythrocyte production in vivo.
Rhondeau
S M
SM
Division of Human Development and Aging, University of Utah School of Medicine, Salt Lake City.
Christensen
R D
RD
Ross
M P
MP
Rothstein
G
G
Simmons
M A
MA
D000751:Anemia, Neonatal / Q000503:physiopathology*; D001853:Bone Marrow / Q000502:physiology; D004921:Erythropoietin / Q000494:pharmacology*; D005312:Fetal Blood / Q000502:physiology; D006801:Humans; D066298:In Vitro Techniques; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000503:physiopathology; D013234:Stem Cells / Q000502:physiology*
D004921:Erythropoietin